Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2009

01.07.2009 | Epidemiology

Complementary and alternative therapies among very long-term breast cancer survivors

verfasst von: C. L. Carpenter, P. A. Ganz, L. Bernstein

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer patients may have different complementary and alternative medicine (CAM) usage rates and may turn to CAM for different reasons than healthy adults. CAM has mostly been studied in recently diagnosed women; no studies have included survivors 10 years post-diagnosis. We examined very long-term breast cancer survivors to determine whether CAM users had dissimilar patterns of association with survivorship factors. Interviews of 374 breast cancer case patients from a population-based case–control breast cancer study of young women from Los Angeles County, California, during the 1980s occurred at follow-up; 371 patients with complete information were included. CAM represented 28 herbal remedies. Quality-of-life originated from the Medical Outcomes Study Short Form 36 questionnaire (SF-36). Higher rates of CAM (59%) usage occurred compared to nationwide estimates. CAM users resembled non-users on follow-up age, exercise, original disease, treatment, smoking, body-mass index, alcohol, and fear of recurrence. CAM users had a higher prevalence of medical co-morbidities (P = 0.0005), and scored significantly lower on the SF-36 emotional well-being subscale than non-CAM users (P = 0.01). CAM users and non-users did not differ on the SF-36 physical sub-scale. Very long-term breast cancer survivors who use CAM may have poorer emotional functioning and more medical problems than non-users.
Literatur
1.
Zurück zum Zitat Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data from Vital Health Stat 343:1–20 Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data from Vital Health Stat 343:1–20
3.
4.
Zurück zum Zitat Boon HS, Olatunde F, Zick SM (2007) Trends in complementary and alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7(4):1–7 Boon HS, Olatunde F, Zick SM (2007) Trends in complementary and alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 7(4):1–7
6.
Zurück zum Zitat Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 100:219–227. doi:10.1007/s10549-006-9239-3 PubMedCrossRef Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 100:219–227. doi:10.​1007/​s10549-006-9239-3 PubMedCrossRef
10.
Zurück zum Zitat Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ et al (2002) Types of alternative medicine used by patients with breast colon or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8:477–485. doi:10.1089/107555302760253676 PubMedCrossRef Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ et al (2002) Types of alternative medicine used by patients with breast colon or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8:477–485. doi:10.​1089/​1075553027602536​76 PubMedCrossRef
11.
Zurück zum Zitat Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality-of-life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMed Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality-of-life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMed
13.
14.
Zurück zum Zitat Enger SM, Ross RK, Henderson BE, Bernstein L (1997) Breast feeding history, pregnancy experience and risk of breast cancer. Br J Cancer 76:118–123PubMed Enger SM, Ross RK, Henderson BE, Bernstein L (1997) Breast feeding history, pregnancy experience and risk of breast cancer. Br J Cancer 76:118–123PubMed
15.
Zurück zum Zitat Mahue-Giangreco M, Ursin G, Sullivan-Halley J, Bernstein L (2003) Induced abortion, miscarriage and breast cancer risk of young women. Cancer Epidemiol Biomarkers Prev 12:209–214PubMed Mahue-Giangreco M, Ursin G, Sullivan-Halley J, Bernstein L (2003) Induced abortion, miscarriage and breast cancer risk of young women. Cancer Epidemiol Biomarkers Prev 12:209–214PubMed
16.
19.
Zurück zum Zitat Ware JE, Kosinski M (1994) SF-36 physical and mental health summary scales: a user’s manual. The Health Institute, Boston Ware JE, Kosinski M (1994) SF-36 physical and mental health summary scales: a user’s manual. The Health Institute, Boston
20.
Zurück zum Zitat Ware JE, Kosinski M, Baylis MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33:AS264–AS279. doi:10.1097/00005650-199501001-00005 PubMedCrossRef Ware JE, Kosinski M, Baylis MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the medical outcomes study. Med Care 33:AS264–AS279. doi:10.​1097/​00005650-199501001-00005 PubMedCrossRef
23.
Zurück zum Zitat Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality-of-life and sexual functioning. J Clin Oncol 16:501–514PubMed Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality-of-life and sexual functioning. J Clin Oncol 16:501–514PubMed
27.
Zurück zum Zitat Statistical Analysis System (2003) SAS Statistics Software, version 9.1.3 Statistical Analysis System (2003) SAS Statistics Software, version 9.1.3
28.
Zurück zum Zitat Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER (2008) The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psychooncology 17:19–25. doi:10.1002/pon.1193 PubMedCrossRef Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER (2008) The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psychooncology 17:19–25. doi:10.​1002/​pon.​1193 PubMedCrossRef
29.
Zurück zum Zitat Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J, Gatto N, Ambs A (2005) The use of complementary and alternative medicine among California adults with and without cancer. Evid Based Complement Alternat Med 2:557–565PubMedCrossRef Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J, Gatto N, Ambs A (2005) The use of complementary and alternative medicine among California adults with and without cancer. Evid Based Complement Alternat Med 2:557–565PubMedCrossRef
30.
Zurück zum Zitat Barry D (1996) Differential recall bias and spurious associations in case–control studies. Stat Med 15:2603–2616. doi :10.1002/(SICI)1097-0258(19961215)15:23<2603::AID-SIM371>3.0.CO;2-GPubMedCrossRef Barry D (1996) Differential recall bias and spurious associations in case–control studies. Stat Med 15:2603–2616. doi :10.1002/(SICI)1097-0258(19961215)15:23<2603::AID-SIM371>3.0.CO;2-GPubMedCrossRef
Metadaten
Titel
Complementary and alternative therapies among very long-term breast cancer survivors
verfasst von
C. L. Carpenter
P. A. Ganz
L. Bernstein
Publikationsdatum
01.07.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0158-3

Weitere Artikel der Ausgabe 2/2009

Breast Cancer Research and Treatment 2/2009 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.